Skip to search formSkip to main contentSkip to account menu

canertinib dihydrochloride

Known as: N-[-4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide Dihydrochloride 
The hydrochloride salt of an orally bio-available quinazoline with potential antineoplastic and radiosensitizing activities. Canertinib binds to the… 
National Institutes of Health

Related topics

Related topics

15 relations

Broader (6)

Antineoplastic AgentsCarbamatesCardiotonic AgentsLocal Anesthetics

Narrower (3)

CI 980CI-1033PD 183805
CanertinibEGFR protein, humanERBB2 protein, humanERBB3 protein, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Canertinib induces ototoxicity in three preclinical models
2007
2007
Gateways to clinical trials.
(-)-Epigallocatechin gallate, [188Re]-P2045, 12B75, 89-12; Abacavir sulfate/lamivudine, Abatacept, Abiraterone acetate, ABT-869… 
2006
2006
APhase I Clinical and Pharmacokinetic Study of Oral CI-1033 in Combinationwith Docetaxel in Patients with Advanced Solid Tumors
Purpose: CI-1033 is an orally available 4-anilinoquinazolone irreversible tyrosine kinase inhibitor of erbB-1, erbB-2, and erbB-4… 
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2005
2005
Canertinib Dihydrochloride : Oncolytic drug HER (ErbB) inhibitor
Dysfunction of intracellular signaling pathways has been implicated in the development and progression of cancer. Canertinib is… 
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Review
2004
Review
2004
Canertinib pfizer.
  • C. Galmarini
  • IDrugs : the investigational drugs journal
  • 2004
  • Corpus ID: 8760051
Canertinib, a water-soluble, orally available analog of PD-169414 (Pfizer Inc), is an EGFR tyrosine kinase inhibitor under… 
2003
2003
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)